Literature DB >> 20457898

Paradoxical suppression of cellular senescence by p53.

Zoya N Demidenko1, Lioubov G Korotchkina, Andrei V Gudkov, Mikhail V Blagosklonny.   

Abstract

The tumor suppressor p53 is a canonical inducer of cellular senescence (irreversible loss of proliferative potential and senescent morphology). p53 can also cause reversible arrest without senescent morphology, which has usually been interpreted as failure of p53 to induce senescence. Here we demonstrate that p53-induced quiescence actually results from suppression of senescence by p53. In previous studies, suppression of senescence by p53 was masked by p53-induced cell cycle arrest. Here, we separated these two activities by inducing senescence through overexpression of p21 and then testing the effect of p53 on senescence. We found that in p21-arrested cells, p53 converted senescence into quiescence. Suppression of senescence by p53 required its transactivation function. Like rapamycin, which is known to suppress senescence, p53 inhibited the mTOR pathway. We suggest that, while inducing cell cycle arrest, p53 may simultaneously suppress the senescence program, thus causing quiescence and that suppression of senescence and induction of cell cycle arrest are distinct functions of p53. Thus, in spite of its ability to induce cell cycle arrest, p53 can act as a suppressor of cellular senescence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20457898      PMCID: PMC2906905          DOI: 10.1073/pnas.1002298107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

Review 1.  Blinded by the Light: The Growing Complexity of p53.

Authors:  Karen H Vousden; Carol Prives
Journal:  Cell       Date:  2009-05-01       Impact factor: 41.582

2.  Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies.

Authors:  Jun Hee Lee; Andrei V Budanov; Eek Joong Park; Ryan Birse; Teddy E Kim; Guy A Perkins; Karen Ocorr; Mark H Ellisman; Rolf Bodmer; Ethan Bier; Michael Karin
Journal:  Science       Date:  2010-03-05       Impact factor: 47.728

3.  p21(Waf1/Cip1/Sdi1) mediates retinoblastoma protein degradation.

Authors:  E V Broude; M E Swift; C Vivo; B-D Chang; B M Davis; S Kalurupalle; M V Blagosklonny; I B Roninson
Journal:  Oncogene       Date:  2007-05-07       Impact factor: 9.867

4.  Activation of p53 stimulates proteasome-dependent truncation of eIF4E-binding protein 1 (4E-BP1).

Authors:  Constantina Constantinou; Androulla Elia; Michael J Clemens
Journal:  Biol Cell       Date:  2008-05       Impact factor: 4.458

5.  Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma.

Authors:  E Drakos; V Atsaves; J Li; V Leventaki; M Andreeff; L J Medeiros; G Z Rassidakis
Journal:  Leukemia       Date:  2009-02-19       Impact factor: 11.528

Review 6.  The tumor suppressor p53: cancer and aging.

Authors:  Zhaohui Feng; Wenwei Hu; Gunaretnam Rajagopal; Arnold J Levine
Journal:  Cell Cycle       Date:  2008-01-23       Impact factor: 4.534

7.  Nutlin-3 inhibits the NFkappaB pathway in a p53-dependent manner: implications in lung cancer therapy.

Authors:  Anwesha Dey; E T Wong; P Bist; V Tergaonkar; David P Lane
Journal:  Cell Cycle       Date:  2007-06-27       Impact factor: 4.534

8.  Growth stimulation leads to cellular senescence when the cell cycle is blocked.

Authors:  Zoya N Demidenko; Mikhail V Blagosklonny
Journal:  Cell Cycle       Date:  2008-11-12       Impact factor: 4.534

9.  Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor.

Authors:  Jean-Philippe Coppé; Christopher K Patil; Francis Rodier; Yu Sun; Denise P Muñoz; Joshua Goldstein; Peter S Nelson; Pierre-Yves Desprez; Judith Campisi
Journal:  PLoS Biol       Date:  2008-12-02       Impact factor: 8.029

10.  p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling.

Authors:  Andrei V Budanov; Michael Karin
Journal:  Cell       Date:  2008-08-08       Impact factor: 41.582

View more
  175 in total

1.  Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence.

Authors:  Marina Kolesnichenko; Lixin Hong; Rong Liao; Peter K Vogt; Peiqing Sun
Journal:  Cell Cycle       Date:  2012-06-15       Impact factor: 4.534

2.  HdmX overexpression inhibits oncogene induced cellular senescence.

Authors:  Kelly R Miller; Kevin Kelley; Rebecca Tuttle; Steven J Berberich
Journal:  Cell Cycle       Date:  2010-08-23       Impact factor: 4.534

3.  TP53 and MTOR crosstalk to regulate cellular senescence.

Authors:  Lorenzo Galluzzi; Oliver Kepp; Guido Kroemer
Journal:  Aging (Albany NY)       Date:  2010-09       Impact factor: 5.682

Review 4.  Genetic control of quiescence in hematopoietic stem cells.

Authors:  Takeshi Yamada; Chun Shik Park; H Daniel Lacorazza
Journal:  Cell Cycle       Date:  2013-06-28       Impact factor: 4.534

5.  Rapamycin induces pluripotent genes associated with avoidance of replicative senescence.

Authors:  Tatiana V Pospelova; Tatiana V Bykova; Svetlana G Zubova; Natalia V Katolikova; Natalia M Yartzeva; Valery A Pospelov
Journal:  Cell Cycle       Date:  2013-12-02       Impact factor: 4.534

6.  Comparison of rapamycin schedules in mice on high-fat diet.

Authors:  Olga V Leontieva; Geraldine M Paszkiewicz; Mikhail V Blagosklonny
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

7.  The NAD+ synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) is a p53 downstream target.

Authors:  Lu-Zhe Pan; Dae-Gyun Ahn; Tanveer Sharif; Derek Clements; Shashi A Gujar; Patrick W K Lee
Journal:  Cell Cycle       Date:  2014-02-07       Impact factor: 4.534

8.  mTORC1 and p53: clash of the gods?

Authors:  Paul Hasty; Zelton Dave Sharp; Tyler J Curiel; Judith Campisi
Journal:  Cell Cycle       Date:  2013-01-01       Impact factor: 4.534

Review 9.  Mechanisms of implantation: strategies for successful pregnancy.

Authors:  Jeeyeon Cha; Xiaofei Sun; Sudhansu K Dey
Journal:  Nat Med       Date:  2012-12       Impact factor: 53.440

10.  Hypoxia suppresses conversion from proliferative arrest to cellular senescence.

Authors:  Olga V Leontieva; Venkatesh Natarajan; Zoya N Demidenko; Lyudmila G Burdelya; Andrei V Gudkov; Mikhail V Blagosklonny
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.